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Abstract: It is unclear if the anti-inflammatory properties of culinary herbs and spices (CHS) are 
linked to their ability to inhibit Colorectal cancer cell (CRC) growth. Furthermore, their therapeutic 
potential with regards to CRC is unknown. The aim of this study was to establish if the inhibition 
of HCA-7 CRC cell growth by a selection of culinary herbs and spices (CHS) is linked to the 
inhibition of the cells’ cyclooxygenase-2 (COX-2 )expression, and to investigate their therapeutic 
potential. CHS inhibited the growth of Human colon adenocarcinoma-7 (HCA-7) cells; the order of 
potency was turmeric, bay leaf, ginger, sage, and rosemary; their combinations had a synergistic or 
additive effect on cell growth inhibition. CHS also inhibited COX-2 expression and activity; this 
action was comparable to that of the specific COX-2 inhibitor Celecoxib. Coincident with COX-2 
inhibition was the accumulation of cells in the sub G1 phase of the HCA-7’s cell cycle and, using 
bay leaf and turmeric, the cleavage of caspase 3 and poly (ADP-ribose) polymerase (PARP). This 
latter effect showed that the effect of these CHS on growth arrest was irreversible, and was 
comparable to that of the caspase activator Etoposide. This study provides evidence of a link 
between the inhibition of HCA-7 growth, and its COX-2 expression, by CHS, and their therapeutic 
potential.  
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1. Introduction 
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in developed countries, 
and cases are rising in developing countries [1,2]. Inflammation, specifically chronic inflammation, 
plays an important role in the development of CRC [3,4]. One key mediator of the inflammatory 
response is the enzyme cyclooxygenase-2 (COX-2) and its product prostaglandin E2 (PGE-2), and 
both are known to promote carcinogenesis [5]. Moreover, it has been found that patient histological 
samples of CRC tumours have overexpressed COX-2 [6–9]. Furthermore, when this enzyme is 
targeted using non-steroidal anti-inflammatory drugs (NSAIDs), the risk of CRC has been shown to 
be reduced [10–12]. However, these drugs have adverse side effects, and hence safer alternatives are 
required [13,14].  
There are numerous foods and food constituents that have been shown to possess anti-
inflammatory effects [14,15], and culinary herbs and spices (CHS) are among them [16–18]. Although 
they are consumed in small amounts, these foods contain high levels of phytochemicals, especially 
polyphenols, which have limited bioavailability, suggesting that a significant part of their action may 
be limited to the gut [19,20]. Studies have shown that some CHS inhibit the growth of CRC cells, 
suggesting that these foods are of potential use in the prevention and treatment of CRC [21–23]. 
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However, despite studies that show that polyphenolic constituents of CHS, primarily curcumin, are 
well established inhibitors of a key inflammatory mediator COX-2 in HCA-7 and HT29 CRC cells 
[3,24–27] there is little information on the effects of CHS. This paucity of information is despite the 
fact that there is a growing amount of interest in the bioactivity of whole foods, not just on their own 
but in combination, so as to know and understand more fully their beneficial potential [20]. Thus, the 
aim of this study was to investigate the effect of a selection of CHS (individually and in combination) 
on HCA-7 CRC cell growth, and its expression of COX-2, ascertain if these activities are linked, and 
determine if the CHS are of therapeutic potential with regards CRC. 
2. Materials and Methods 
2.1. Preparation of Culinary Herb and Spice (CHS) Extracts  
The CHS were purchased online from Neal’s Yard remedies (London, UK): bay leaf (Laurus 
nobilis), rosemary (Rosmarinus officinalis), sage (Salvia officinalis), ginger (Zingiber officinale), and 
turmeric (Curcuma longa). The selection of the CHS was based on preliminary potency studies. These 
CHS were extracted using a method adapted from Huang et al. [28] with some modifications. Briefly, 
herbs/spices, with the exception of ginger and turmeric, which were purchased in powder form, were 
ground up using a pestle and mortar and then 2 g of ground herb were added to a glass bottle and 
extracted in 25 mL of solvent (deionised water or 42% ethanol (v/v)). The bottles were then wrapped 
in aluminium foil and placed on an orbital shaker (Jeiotech OS-7100, Fisher Scientific, Loughborough, 
Leicestershire, UK) for 2.5 h Thereafter, the contents were transferred into a sonicator (Elmasonic S 
10H ultrasonic bath, Fisher Scientific, Leicestershire, UK) and sonicated for 70 min at a frequency of 
35 kHz. After sonication, the extracts were filtered using a two-stage filtration process: for Stage 1, 
the extracts were filtered using Whatman No. 1 filters (Whatman, Fisher Scientific, Loughborough, 
Leicestershire, UK) to separate the extract from any solid material and then to make the extract more 
pure for Stage 2 a Whatman No. 6 filter paper (Whatman, Fisher Scientific, Loughborough, 
Leicestershire, UK) was used. The filtered extracts were then aliquoted and stored at −80 °C. The 
extracts prepared were turmeric in ethanol (TE), ginger in ethanol (GE), bay leaf in ethanol (BLE), 
sage in ethanol (SE), sage in water (SA), rosemary in ethanol (RE), and rosemary in water (RA). The 
extracts prepared were based on preliminary potency studies as with the selection of CHS. The effect 
of combinations of CHS was also investigated to determine if they had any additive/synergistic effect. 
All the combinations used in this study were prepared by using half of the concentration of each 
extract that was used individually for the same experiment. The concentration of the extract was 
based on their phenolic content (μg gallic acid equivalents (GAE)/mL). Based on preliminary potency 
studies, the following combinations were used: rosemary in water and rosemary ethanol (RAE), sage 
in water and sage ethanol (SAE), bay leaf and turmeric ethanol (BLTE), sage and ginger ethanol (SGE), 
bay leaf and sage ethanol (BLSE), and rosemary and turmeric ethanol (RTE). 
The total phenolic content for each herb and spice extract was determined using the Folin–
Ciocalteu (F-C) colorimetric method used by Singleton et al. [29] and modified by Tang et al. [30]. To 
determine if any of the observations were related to the CHS’ polyphenol content or simply their 
weight, the concentrations of the extracts were expressed as as gallic acid equivalents (GAE) for the 
total polyphenol content, and dry weight (DW) equivalents (for 1 g of dry weight).  
2.2. Growth Inhibition Studies: Effect of Herb and Spice Extracts (Individual and in Combination) on 
Growth of HCA-7 Cells 
HCA-7 CRC cells, obtained from Culture Collections Public Health England, were grown in 
Dulbecco Modified Eagle Medium (DMEM) (Sigma-Aldrich, Poole, Dorset, UK, D5796) supplemented 
with 10% foetal bovine serum (FBS) (Sigma-Aldrich, Poole, Dorset, UK, F7524) and antibiotics: 
penicillin (50 units per mL), streptomycin (0.05 mg/mL), and neomycin (0.1 mg/mL), at 37 °C, 5% CO2 
atmosphere. The growth inhibition studies were first performed using the sulforhodamine B (SRB) assay, 
and the protocol was adapted from Khelwatty et al. [31]. In brief, confluent HCA-7 cells were trypsinised 
and re-suspended in DMEM with 10% FBS and then seeded on to 96-well plates (10,000 cells suspended 
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in 100 μL of DMEM per well) and placed into an incubator for four hours. The CHS were then prepared 
using a doubling dilution technique; the starting concentration for each extract was 20 μg GAE/mL. 
Following the 4 h incubation period, the CHS extracts (100 μL) at various concentrations (individually 
and in combination) were added to the wells. Cells were treated with the extracts for 5 days until the 
control wells (DMEM containing 10% FBS only) reached confluence. Thereafter, the plate was fixed 
for 1 h with 10% trichloroacetic acid (TCA), then washed with tap water, dried and stained with 
sulforhodamine B (SRB) (0.4% (w/v) in acetic acid (1%, v/v) (100 μL per well) for 1 h Thereafter, SRB 
was removed and the stain was re-solubilised by adding 100 μL Tris-base (10 mM) into each well, 
and absorbance was then read at 565 nm using an Epoch microplate reader (Biotek, Swindon, UK).  
To determine if the effect of the CHS was cancer cell specific, the effect of some of the most potent 
CHS on the growth of normal cells, human foreskin fibroblasts (HFF-2 cells) donated by Dr. Chioni 
(Kingston University London, Kingston upon Thames, UK) and were a gift from Dr. Richard Grose 
(Queen Mary, University of London, London, UK) was also investigated, using the same protocol 
described above for the HCA-7 cell line.  
2.3. The Effect of Culinary Herb and Spice Extracts on COX-2 Expression in HCA-7 CRC Cells  
Based on the growth inhibition studies, described above, specifically the potency of the extracts 
RE, SE, BLE, GE, TE, RTE, BLSE, SGE, and BLTE were chosen to study their effect on COX-2 
expression in HCA-7 CRC cells. HCA-7 cells were seeded into 6-well plates (Nunclon delta, Fisher 
Scientific, Loughborough, LeicestershireUK) with Dulbecco’s modified Eagle’s medium (DMEM) 
(500 mL) in 10% foetal bovine serum (FBS) and incubated at 37 °C and 5% CO2. After 48 h, when the 
cells were almost 80% confluent, the CHS extracts were added and left for another 24 h The 
concentrations of the CHS used were based on their highest tolerated concentrations. Controls were 
also set up and these were: “no treatment” (HCA-7 cells in cell culture medium only); ethanol control 
(HCA-7 cells exposed to the equivalent volume of ethanol in the extracts, i.e., 0.2% v/v); and a positive 
control—HCA-7 cells exposed to a specific COX-2 inhibitor, Celecoxib (Sigma-Aldrich, Poole, Dorset, 
UK) (50 μM) [5,32], which was used at the highest concentration that could be tolerated by the cells 
without killing them. A positive control was used to gain some idea of the therapeutic potential of 
the CHS as Celecoxib has been shown to reduce adenomas in humans [33]. Celecoxib was made up 
in dimethyl sulfoxide (DMSO). After incubation with the CHS or the control, cells were lysed using 
LDS NUpage lysis buffer (Fisher Scientific, Loughborough, Leicestershire UK, 10718414) and then 
Western blotting was performed using equal amounts of sample (lysed cells) based on protein 
content, which was 30 μg. Following electrophoresis, the separated proteins were transferred on to 
Immobilon® PVDF membranes (IPFL 00010; Merck Millipore, Watford, Hertfordshire, UK). 
Thereafter, the membrane was placed in blocking solution for at least 1 h and then primary antibodies 
were applied: COX-2(D5H5) XP® Rabbit mAb #12282 (Cell Signalling, Leiden, Netherlands), (dilution 
1:1000) and β-actin (1:1000; Cell Signalling, , Leiden, Netherlands) which was used as an internal 
control to show that equal amounts of protein were loaded. After incubating with the primary 
antibody, the membranes were washed with wash solution (5 min 3 times) and incubated with IRDye 
689 Rd, donkey anti-Rabbit secondary antibody (LI-COR, Cambridge, UK). The signal was detected 
and quantified using LI-COR Image studio (LI-COR, Cambridge, UK).  
2.4. The Effect of Culinary Herb and Spice Extracts on COX-2 Activity, Based on PGE-2 Release, in HCA-7 
CRC Cells  
The same CHS used in the COX-2 expression experiments were also used to investigate their 
effect on COX-2 activity in HCA-7 cells, which was determined by measuring their release of PGE-2. 
From the Western blot experiments, cell culture medium was collected and stored at −20 °C. Prior to 
carrying out the PGE-2 assay, samples were defrosted, centrifuged at 1000 rpm for 4 min and then 
assayed using a PGE-2 ELISA kit according to the manufacturer’s instructions (RND Systems, 
Abingdon, UK, KGE004B). To further investigate the effect of the CHS on COX-2 activity, the effect 
of the two most potent COX-2 CHS inhibitors, BE and TE, on COX-2 enzyme activity and PGE-2 
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production, in vitro, was investigated using COX-2 Inhibitor Screening Assay Kit (CAY560131-96; 
Cayman, Cambridge Bioscience, Cambridge, UK).  
2.5. The Effect of CHS Extracts on HCA-7 Cell Viability at 24, 48 and 72 h 
The CHS found to have the strongest inhibitory effect on COX-2 expression were investigated 
to determine if and how they affected cell viability over the same time period (24 h) that their effect 
on COX-2 expression and activity was investigated. The CHS used were TE, GE, BLE, BLTE, and SGE. 
Cell growth was determined using the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
Bromide) assay: cells were trypsinised and seeded on 96-well plate and left for 24 h, thereafter the 
CHS extracts were added at concentrations based on the SRB investigation: 20, 10, 5, 2.5, 1.25, 0.625, 
0.313, and 0.156 μg GAE/mL. Following the treatment periods (24 h as this was the period used for 
the COX-2 experiments, and also 48 and 72 h), the media containing the CHS extracts were removed 
and MTT (Sigma-Aldrich, Poole, Dorset, UK) (0.5 mg/mL) added. After 4 h, media containing MTT 
were removed and DMSO was added to solubilize the cells. Absorbances were then read at 570 nm 
(Epoch microplate reader, Biotek, UK) and the effect of the CHS on cell viability was determined and 
expressed in IC50 values. An additional experiment was performed to investigate what would 
happen if the CHS were removed after 24 h and replaced with fresh media and left for another 48 h. 
We hypothesised that, if after their removal, their IC50 values were similar to those obtained for the 
72 h treatment, their action was cytotoxic. The lactate dehydrogenase (LDH) cytotoxic assay was also 
performed (Promega, Southampton, UK) to confirm cytotoxicity using the two most potent CHS 
extracts, BLE and TE, and their combination (BLTE). The latter was done to determine if the 
combination had a synergistic or antagonistic effect. The concentrations of the extracts were the same 
as for SRB and MTT assays and the treatment period was 72 h. The assay procedure was followed 
using the manufacture’s protocol. 
2.6. The Effect of CHS on the Cell Cycle and Apoptosis in HCA-7 CRC Cells 
Based on the results of the cell viability/cytotoxicity experiments, the most potent CHS extracts 
and their combinations were tested for their effect on cell cycle distribution (i.e., percentage of cells 
in sub G1, G1, S, and G2), and induction of apoptosis using FACS analysis. The CHS investigated 
were TE, GE, BLE, SE, RE, BLTE, BLSE, RTE, and SGE. Trypsinised cells (1 × 106) were seeded into a 
flask containing 10 mL of cell culture medium and CHS extract. The doses used for the cell cycle 
analysis were based on the SRB growth inhibition study, and were slightly higher than their IC50 
values (their approximate IC70) so that an effect could be observed without the CHS killing a large 
proportion of the cells. The exception was TE, for which a lower than IC50 dose was used because at 
the higher (approximate IC70) dose TE was killing most of the cells. Following the same exposure 
periods of 24 and 48 h used in the MTT cell viability experiments described above, supernatant and 
trypsinised cells were pooled together. Then cells were washed three times by centrifugation (at 1000 
rpm for 4 min) and re-suspended in cold (4 °C) phosphate buffered saline (PBS). After the final wash, 
cells were re-suspended in 200 μL of cold PBS and fixed by adding 1 mL of ice cold 70% ethanol (in 
PBS). Cells were then kept overnight at 4 °C, and then washed 3 times as above. Thereafter, cells were 
incubated with 0.5 mL of propidium iodide (PI) buffer (BD Biosciences, Oxford, UK) for 30 min at 
room temperature and analysed using a FL3 detector (PI detector, 620 nm) (FACS calibur, BD 
Biosciences, Oxford, UK). At least 10,000 events were counted. Cells present in the sub G1 phase were 
considered to be apoptotic [34–36]. 
To confirm that apoptosis had occurred, a caspase-3/7 assay was performed using IncuCyte live-
cell imaging according to the manufacturer’s instructions (EssenBioscience, Welwyn Garden City, 
Hertfordshire, UK). Briefly, cells were seeded on 96-well plates and placed into an incubator for 24 
h, then one of the most potent extracts (BLE) was added at its approximate IC70 (for the reasons stated 
above) (6 μg GAE/mL) with the caspase-3/7 reagent. A caspase-3/7 inhibitor and Etoposide (Tocris 
Bioscience, Bristol, UK), a caspase activator, were used as a positive control for caspase 3 activation 
and a negative control, respectively. Another negative control (media without caspase-3/7 reagent) 
was set up to make sure cell culture medium did not generate a fluorescence signal. The untreated 
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control contained just cell culture medium and caspase-3/7 reagent. On caspase-3/7 activation the 
probe emits a green fluorescent light which is detected by the IncuCyte camera. Cells were treated 
with the CHS extracts for 48 h and constantly monitored (images were taken every 2 h), and the data 
were analysed using IncuCyte ZOOM® software (EssenBioscience, Welwyn Garden City, 
Hertfordshire, UK). 
To further investigate the effect of the CHS on apoptosis, their (BLE and TE) effect on key protein 
markers of apoptosis were determined: cleaved caspase-3, p53, and cleaved PARP. Etoposide (25 μM) 
was used as a positive control for caspase-3 activation. All antibodies were purchased from Cell 
Signalling. The cell preparation and treatment were the same as for the COX-2 experiments. 
2.7. Data Expression and Statistical Analysis 
All experiments were done in triplicate (n = 3), which represents three separate experiments, and 
data are expressed as mean and standard error of the mean (±standard error mean (SEM)) unless 
otherwise stated. Growth inhibition data (SRB and MTT) are presented as 50% inhibitory 
concentration (IC50), the concentration at which 50% of cell growth is inhibited compared to the no 
treatment group (the control for which cell growth is 100%). The IC50 concentration was determined 
for each CHS (individual and in combination) extract (unless IC50 was not achieved) using Gen5 
(Biotek, Swindon, UK) software and expressed as μg GAE/mL and DW equivalents μg/mL in order 
to show the importance of polyphenols found in the CHS extracts. To determine if synergy occurred 
as a result of the CHS combinations, the interaction factor (IF) was calculated for each combination 
using the analysis described by Gawlik-Dziki (2011). IF = IC50 value for combination/(IC50 value for 
herb1/2 + (IC50 value for herb2/2). IF values of <1 indicate synergy, IF values >1 indicate antagonism, 
and IF value of 1 indicate an additive effect. 
Western blot band intensity was analysed using Odysey software (LI-COR, Cambridge, UK), the 
data were normalised against β-actin and any reduction in band intensity was expressed as a 
percentage in comparison with the intensity of the “no treatment” band (HCA-7 cells in cell culture 
medium only) which represented 100% expression. 
COX-2 activity was determined based on PGE-2 release data, which are expressed as per cent 
reduction, in comparison to the control (HCA-7 cells in cell culture medium only), which represented 
100% activity. One-way ANOVA with Tukey’s post-hoc test was performed to assess whether the 
differences in effect of the extracts were statistically significant. Pearson’s correlation coefficient (r) 
(2-tailed) was used to determine correlations between COX-2 expression, and PGE-2 production. To 
compare the IC50 values for the anti-proliferative, cell viability and cytotoxicity experiments, the 
independent sample test was performed. For all statistical tests, SPSS software was used and p < 0.05 
was considered statistically significant.  
To determine if there was a statistically significant difference between treated (exposed to CHS) 
and untreated cells for the sub G1 phase, one-way ANOVA with Tukey’s post-hoc test was 
performed.  
3. Results 
3.1. Effect of the CHS and Their Combinations on HCA-7 Cell Growth Using the SRB Assay 
The CHS and their combinations were screened for anti-proliferative activity against the HCA-
7 CRC cell line. TE (IC50: 3 ± 0.1 μg GAE/mL), BLE (4.7 ± 0.2 μg GAE/mL), and GE (5.5 ± 0.3 μg 
GAE/mL) were found to be the most effective extracts at inhibiting HCA-7 cell growth. For the 
combinations, BLTE produced the lowest IC50 value (3.3 ± 0.7 μg GAE/mL), followed by RTE (6 ± 0.4 
μg GAE/mL) (Table 1). Treatment with a combination of CHS extracts was found to be synergistic in 
the majority of cases including SGE (IF = 0.67), SBLTE (IF = 0.80), and BLTE (IF = 0.90), and additive 
for RAE (IF = 0.98). In contrast, treatment with RTE was found to be antagonistic with (IF = 1.20) 
(Table 2). For the non-cancer cell line HFF-2, the extracts, specifically the most potent against HCA-
7, BLE and TE, proved to be less potent based on their IC50s, which were 7.1 ± 0.6 μg GAE/mL and 7.1 
± 0.9 μg GAE/mL, respectively. 
Nutrients 2017, 9, 1051 6 of 22 
 
Table 1. The effect of CHS and their combinations on HCA-7 cell growth using the SRB assay.  
Herb/Spice/Combinations IC50 (μg GAE/mL) IC50 (μg/mL of DW)
TE 3.0 (±0.3) 300 
BLTE 3.3 (±0.7) 227 
BLE 4.7 (±0.2) 177 
GE 5.5 (±0.3) 417 
BLSE 5.5 (±0.3) 180 
RTE 6.0 (±0.4) 382 
SGE 6.8 (±0.1) 352 
SE 12.5 (±0.9) 347 
SAE 15.7 (±0.6) 414 
RE 15.9 (±0.4) 347 
RAE 16.2 (±0.4) 432 
RA 17.1 (±0.1) 442 
SA >20 (n/a) >442 
GAE: gallic acid equivalent, used to express the total polyphenol content. The IC50 values are also 
expressed in dry weight (DW) equivalent of the herb/spice. Culinary herbs and spices (CHS), 
sulforhodamine B (SRB), Turmeric in ethanol (TE), ginger in ethanol (GE), bay leaf in ethanol (BLE), 
sage in ethanol (SE), sage in water (SA), rosemary in ethanol (RE) and rosemary in water (RA), 
rosemary in water and rosemary ethanol (RAE), sage in water and sage ethanol (SAE), bay leaf and 
turmeric ethanol (BLTE), sage and ginger ethanol (SGE), bay leaf and sage ethanol (BLSE), and 
rosemary and turmeric ethanol (RTE). Each value is the values are expressed as mean of triplicate 
samples, ±SEM, n = 3.  
Table 2. IF * index for CHS extract combinations based on SRB assay. 
Combinations HCA-7 
RAE 0.98 
SAE n/a 
RTE 1.20 
BLTE 0.90 
SGE 0.67 
SBLE 0.80 
Bay leaf and turmeric ethanol (BLTE), sage and bay leaf ethanol (SBLE), rosemary aqueous ethanol 
(RAE), sage aqueous and ethanol (SAE), and sage and ginger ethanol (SGE). * The IF value for SAE 
could not be calculated because the IC50 value for SA was not achieved. 
3.2. The Effect of CHS Extracts on COX-2 Expression in HCA-7 CRC Cells 
Based on the SRB results, the most potent extracts were used for the COX-2 experiments. As 
shown in Figure 1, treatment with individual extracts RE, SE, BLE, GE, and TE resulted in the 
reduction of COX-2 expression in HCA-7 cells (Figure 1a,b). The strongest effect was seen with the 
highest tested concentrations that were tolerated by the cells (i.e., 40 μg GAE/mL for RE and SE; 15 
μg GAE/mL for GE and BLE, and 10 μg GAE/mL for TE). BLE and TE extracts were the most potent; 
they reduced COX-2 expression by 59% and 57% respectively. The four combinations used, RTE, 
BLTE, SGE, and SBLE, reduced COX-2 expression by 53%, 60%, 58% and 62%, respectively. The 
effects of the most potent of the CHS extracts and combinations were slightly less but of the same 
magnitude as that of the selective COX-2 inhibitor Celecoxib (50 μM), which reduced COX-2 
expression by 70%. 
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(a) 
COX-2 (72 kDa) 
 β-Actin (45 kDa) 
(b) 
 
Figure 1. Effect of CHS extracts on on COX-2 expression: (a) Western blot; and (b) quantitative 
analysis of COX-2 bands. Data are expressed in comparison to control (100%) after the signal was 
normalized against β-actin. rosemary ethanol (RE); sage ethanol (SE); bay leaf ethanol (BLE), ginger 
ethanol (GE), and turmeric ethanol (TE) and their combinations (rosemary and turmeric ethanol 
(RTE), bay leaf and sage ethanol (BLSE), sage and ginger ethanol (SGE) on COX-2 expression in HCA-
7 cells. * Statistically significant different from control (p < 0.05), n = 3, ±SEM. Untreated control 
contained just DMEM with 10% FBS (vehicle control–ethanol was 0.4% (v/v), the highest amount 
found in the extracts).  
3.3. The Effect of Culinary Herb and Spice Extracts on COX-2 Activity, Based on PGE-2 Release, in HCA-7 
CRC Cells  
Treatment with the CHS extracts resulted in significant inhibition of PGE-2 release with TE 
(92%), BLE (91%), and GE (88%) almost completely inhibiting its release. Of the combinations, BLTE 
(92%) and RTE (91%) had the strongest inhibitory effect (Figure 2). Celecoxib (50 μM) reduced the 
PGE-2 release by 97% (Figure 2). Furthermore, most extracts produced a stronger reduction in PGE-
2 release than COX-2 expression. There was a strong (r = 0.78) statistically significant (p < 0.05) 
correlation between PGE-2 release and COX-2 expression.  
To confirm that BLE and TE directly targets COX-2 activity, rather than just purely reducing its 
expression, and that the effect observed was not due to the inhibition of HCA-7 cell growth by the 
CHS, an in vitro COX-2 inhibition screening assay was performed. The assay revealed that BLE and 
TE reduced PGE-2 production by 53% and 25%, respectively (Figure 3). 
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Figure 2. Effect of CHS (RE, SE, BLE, GE, and TE) and their combinations (RTE, BLSE, SGE, and BLTE) 
on PGE-2 release from HCA-7 cells. * Untreated control contained just DMEM with 10% FBS (vehicle 
control–ethanol was 0.4% (v/v), the highest amount found in the extracts). Rosemary ethanol (RE), 
sage ethanol (SE), bay leaf ethanol (BLE), ginger ethanol (GE), turmeric ethanol (TE), and rosemary 
and turmeric ethanol (RTE), bay leaf and sage ethanol (BLSE), sage and ginger ethanol (SGE), bay leaf 
and turmeric ethanol (BLTE). * Indicates statistically significant difference from control (p < 0.05), n = 
3, ±SEM. 
 
Figure 3. BLE and TE effect on COX-2 activity and PGE-2 production. Untreated control contained 
the same volume of ethanol that was found in extracts to ensure that the final reaction volume would 
be the same. DW equivalents for BLE (bay leaf in ethanol) 15 μg GAE/mL = 566 μg/mL and for TE 
(turmeric in ethanol) 10 μg GAE/mL = 1000 μg/mL. * Indicates statistically significant difference from 
control (p < 0.05), n = 3, ±SEM.  
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3.4. The Effect of CHS Extracts on HCA-7 Cell Viability at 24, 48, and 72 h 
The CHS extracts that possessed the strongest COX-2 inhibitory activity were then used to 
determine their effect on cell viability over the same period used for the COX-2 experiments. TE had 
the lowest IC50 values across all three time points (24, 48, and 72 h): 6 ± 0.1, 2.1 ± 0.5, and 2.5 ± 0.3 μg 
GAE/mL, respectively (Table 3). At the 24 h time point, for all extracts and combinations, the IC50 
values were higher than those for the 48 and 72-h treatments. The impact of removing the treatment 
and replacing it with fresh medium was also investigated. Results revealed that the removal of 
extracts after 24 h did not have a significant effect on the IC50 values, in comparison to the whole 72-
h treatment, the difference between the IC50 values were statistically insignificant (Table 3), 
suggesting that the effect of the CHS extracts is cytotoxic. To confirm their cytotoxic action, a LDH 
assay was performed using the most potent CHS extracts, TE and BLE, and results clearly indicate 
that at the higher concentration (5, 10, and 20 μg GAE/mL) both produced cytotoxic effects (Figure 
4). 
Table 3. Effect of CHS and their combinations on HCA-7 cell viability using MTT assay. 
Herbs/
Spices 24 H 48 H 72 H 
Extracts Removed 
from Media * 
 
IC50 (μg GAE/mL) 
(±SEM) 
IC50 (μg GAE/mL) 
(±SEM) 
IC50 (μg GAE/mL) 
(±SEM) 
IC50 (μg GAE/mL) 
(±SEM) 
TE 6.0 (±0.1) 2.1 (±0.3) 2.5 (±0.2) 2.5 (±0.4) 
GE 10.0 (±0.5) 6.1 (±0.6) 5.8 (±0.1) 7.8 (±0.8) 
BLE 10.5 (±0.3) 6.0 (±0.5) 9.2 (±0.2) 8.4 (±0.6) 
BLTE 11.1 (±0.9) 4.9 (±0.5) 3.6 (±0.6) 3.7 (±0.6) 
SGE 11.1 (±0.8) 10.7 (±0.5) 10.9 (±0.8) 11.3 (±0.9) 
* Extracts removed after 24 h and replaced with fresh media and left for another 48 h. Difference 
between the IC50 values were statistically insignificant compared to 72 h treatment p > 0.05; n = 3. GAE: 
gallic acid equivalent, which is used to express the total polyphenol content. Turmeric ethanol (TE), 
ginger ethanol (GE), bay leaf ethanol (BLE), bay leaf and turmeric ethanol (BLTE), sage and ginger 
ethanol (SGE). 
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Figure 4. Cytotoxic effect of CHS against HCA-7 cells using LDH assay. BLE (bay leaf in ethanol), TE 
(turmeric in ethanol), BLTE (bay leaf and turmeric in ethanol). † Data are expressed as a percentage of 
maximum release of lactate dehydrogenase (LDH), n = 3. 
3.5. The Effect of CHS on the Cell Cycle and Apoptosis in HCA-7 CRC Cells  
In light of the results of the growth inhibition experiments, the most potent CHS extracts and 
their combinations were tested for their effect on HCA-7 cell cycle regulation 24 h post treatment. As 
shown in Table 4, these treatments resulted in an increased number of cells undergoing apoptosis 
due to their accumulation in the sub G1 phase of the cell cycle (Table 4). BLE and GE were the most 
potent extracts, causing 28% and 27%, respectively, of the cells to accumulate in the sub G1 phase. Of 
the combinations, treatment with BLTE induced the greatest percentage of cells (33%) being 
accumulated in the sub G1 phase 24 h post treatment. These effects were more pronounced when the 
cell cycle analysis was conducted 48 h post treatment (Table 4). Treatment with BLTE and RTE 
combinations resulted into 35% and 33% of cells entering the sub G1 of the cell cycle. BLTE treatment 
was also accompanied by a reduction in the number of cells in the S and G2 phases of the cell cycle. 
To confirm apoptosis, a caspase-3/7 assay was performed with one of the most potent extracts, BLE. 
The results showed that BLE extract (6 μg GAE/mL) activated caspase-3/7 (Figures 5 and 6) and that 
the activation of caspase-3/7 by BLE was not inhibited by the presence of the caspase-3/7 inhibitor. 
Finally, the effects of the most potent extracts (BLE and TE) on proteins markers for apoptosis (i.e., 
cleaved PARP and cleaved caspase 3) were investigated to ascertain further how apoptosis was 
induced by these CHS. Both extracts increased the expression of cleaved caspase-3, and cleaved PARP 
and the increase was comparable to that of the caspase 3 activator - Etoposide. In contrast, BLE did 
not affect the expression of p53 whilst its expression was reduced slightly following treatment with 
TE (Figure 7a,b).  
HCA-7 cells were treated with BLE (6 μg GAE/mL); Etoposide (25 μM) was used as a positive 
control for caspase-3 activation, caspase-3/7 inhibitor (100 μM) was used as a negative control. 
Another negative control—(media without caspase-3/7 reagent) was used to ensure the cell culture 
media does not generate fluorescence signal. Vehicle control—0.2% ethanol (v/v). Before the first scan 
was performed by the the IncuCyte ZOOM®, cells were exposed to the treatment for ~30 min so time 
0 is approximately 30 min after cells were exposed. On caspase-3/7 activation, the reagent turned 
green and was recorded by IncuCyte ZOOM® camera. 
 
Figure 5. BLE effect on cell death and caspase-3/7 activation. 
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Table 4. The Effect of CHS on the cell cycle in HCA-7 cells over 24 and 48 h. 
Herbs/Spices Sub G1 (%) (±SEM) G1 (%) (±SEM) S (%) (±SEM) G2 (%) (±SEM) 
 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 
Untreated control 10 (±1.3) 7 (±1.4) 40 (±1.5) 46 (±1.0) 26 (±1.2) 25 (±2.3) 23 (±1.2) 20 (±2.9) 
Vehicle control (ethanol) 9 (±1.2) 4 (±0.7) 41 (±1.6) 47 (±1.3) 27 (±1.2) 24 (±1.2) 23 (±0.4) 23 (±0.3) 
Vehicle control (H2O) 10 (±1.0) 4 (±1.0) 39 (±0.9) 45 (±0.6) 25 (±1.8) 25 (±0.3) 24 (±1.2) 23 (±0.3) 
TE (2 μg GAE/mL) 23 (±4.0) * 49 (±3.1) * 41 (±3.2) 21 (±4.7) 20 (±0.3) 19 (±1.2) 15 (±0.9) 9 (±0.6) 
GE (8 μg GAE/mL) 27 (±3.9) * 49 (±3.1) * 41 (±2.3) 25 (±2.9) 17 (±0.3) 15 (±1.2) 12 (±0.6) 8 (±0.7) 
BLE (6 μg GAE/mL) 28 (±3.2) * 43 (±2.5) * 38 (±3.4) 28 (±1.5) 20 (±1.8) 15 (±1.2) 13 (±1.8) 12 (±1.0) 
SE 16 μg GAE/mL 16 (±2.3) 30 (±1.3) * 42 (±0.3) 31 (±4.2) 23 (±1.2) 21 (±3.5) 18 (±1.5) 17 (±0.3) 
RE (20 μg GAE/mL) 14 (±0.3) 17 (±4.3) 42 (±0.9) 41 (±1.2) 31 (±0.7) 20 (±0.4) 10 (±0.3) 20 (±1.6) 
BLTE (3 μg GAE/mL BL and 1 μg GAE/mL TE) 33 (±0.9) * 33 (±0.6) * 34 (±0.3) 35 (±1.3) 19 (±0.6) 16 (±0.7) 11 (±0.7) 14 (±1.5) 
BLSE (3 μg GAE/mL BL and 8 μg GAE/mL SE) 19 (±0.8) * 26 (±1.8) * 41 (±0.8) 42 (±3.2) 18 (±1.6) 18 (±1.7) 12 (±0.4) 14 (±1.0) 
RTE (10 μg GAE/mL RE and 1 μg GAE/mL TE) 16 (±0.9) * 35 (±0.3) * 42 (±1.5) 32 (±2.5) 26 (±2.3) 17 (±1.2) 18 (±0.3) 12 (±0.3 
SGE (8 μg GAE/mL SE and 4 μg GAE/mL GE) 23 (±0.3) * 22 (±1.2) 37 (±0.7) 45 (±0.7) 27 (±0.3) 20 (±0.6) 11 (±0.6) 12 (±1.0) 
Celecoxib (50 μM) 23 - 45 - 18 - 13 - 
Data are expressed as a percentage of cells in each phase (n = 3). * Statistically significant difference in comparison to control (p < 0.05). Vehicle control (ethanol)—
0.2% (v/v), the highest volume found in the extracts. Vehicle control (filtered, sterilised and distilled H2O) 0.7% (v/v), the highest volume found in the extracts. 
Rosemary ethanol (RE), sage ethanol (SE), bay leaf ethanol (BLE), ginger ethanol (GE), turmeric ethanol (TE), and rosemary and turmeric ethanol (RTE), bay leaf 
and sage ethanol (BLSE), sage and ginger ethanol (SGE), bay leaf and turmeric ethanol (BLTE).  
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 Untreated Control Etoposide 25 μM 6 μg GAE/mL 
Treatment 
period  
0 h * 
 
24 h 
 
48 h 
 
Figure 6. BLE effect on caspase activation. Images recorded using the IncuCyte ZOOM® camera (×10 
zoom). HCA-7 cells were treated with bay leaf ethanol (BLE) at 6 μg GAE/mL concentration. * The 
first scan taken by the IncuCyte ZOOM®; before the first scan was performed cells were exposed to 
the treatment for ~30 min. 
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(a) 
 Cleaved PARP (89 kDa) 
 p53 (53 kDa) 
 
Cleaved caspase3 (17 and 
19 kDa) 
 β-Actin (45 kDa) 
(b) 
 
Figure 7. BLE and TE effect on proteins markers for apoptosis in HCA-7 cell line. (a) Western blot” 
Cells were treated for 24 h with bay leaf (BLE 15 μg GAE/mL), turmeric (TE 10 μg GAE/mL), and 
Etoposide 25 μM, which was used as a positive control for caspase-3 activation. (a) Quantitative 
analysis of Western blot bands. Protein expression was normalised against β-Actin and expressed 
relative to untreated control, where control is 100%; (b) Untreated control contained just DMEM with 
10% FBS (vehicle control–ethanol was 0.4% (v/v), the highest amount found in the extracts). Bay leaf 
in ethanol (BLE), turmeric in ethanol (TE), n = 3, ±SEM.  
4. Discussion 
The aim of the present study was to investigate the effect of a selection of CHS (individually and 
in combination) on COX-2 expression and activity in HCA-7 CRC cells and to establish if this activity 
is linked to any inhibition by the CHS of the growth of these cells. 
Some research suggests that whole food extracts can be more effective than isolated compounds 
[37–39], and the present study clearly demonstrates the potential benefits of CHS, individually and 
in combination, in relation to CRC. The IC50s established using the SRB and MTT assays as GAE and 
DW equivalents clearly show that the action of these CHS is likely due to their polyphenolic 
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constituents and not the amount of the CHS used, as their potency in IC50 expressed as μg GAE/mL 
differs from those expressed as per gram of dry weight. In addition, bearing in mind that the 
polyphenol profiles of the CHS differ, the data suggest that specific polyphenols in the CHS influence 
the effect on CRC cell growth.  
The growth inhibition results are in line with other studies that demonstrated that CHS possess 
anti-proliferative activity against various cancer cell lines including CRC [22,23,36,40–42]. However, 
to our knowledge, none of the above-cited studies investigated the effect of the CHS used in the 
present study (individually or in combination) on the HCA-7 CRC cell line. The SRB growth 
inhibition results also suggest that the action of the CHS may be cancer cell specific as they, 
specifically BLE and TE, had a far less potent effect when exposed to the HFF-2 fibroblast cells. These 
data are supported by growth experiments using Incucyte which show that the doses of BLE and TE 
required to inhibit HCA-7 cell growth were lower than those required to inhibit the growth of the 
HFF-2 cells (see Supplementary Materials, Figures S1 and S2).  
The majority of tested CHS extracts clearly inhibited the growth and reduced viability of HCA-
7cells, as shown using the SRB, MTT, and LDH assays, (Tables 1 and 2). Interestingly, for the same 
extracts, the IC50 values varied when determined using the SRB and MTT assays. The differences in 
the IC50 values could be explained by the different mechanisms upon which these assays are based: 
MTT utilises NAD(P)H-dependent cellular oxidoreductase enzymes that convert colourless tetra-
zolium to the purple-coloured formazan dye, whilst SRB measures cell mass and does not distinguish 
between dead and live cells [43]. In addition, it must also be noted that for the MTT experiments the 
exposure times were shorter than that for the SRB assay. Nevertheless, TE, GE, and BLE were the 
most potent extracts based on both assays. 
Combinations of the CHS were also investigated to determine if combining them had an 
additive, synergistic or possibly even an antagonistic effect on cell growth. Based on the results of the 
SRB assay, the most potent combination (BLTE) included two of the most potent individual CHS 
constituent extracts (TE and BLE) (based on the SRB and MTT assays (Tables 1 and 2)). The 
combinations that included TE, BLTE, and RTE, were less potent than TE, which was the strongest 
individual CHS extract. In fact, based on the IC50 values alone, none of the combinations were more 
potent than both their constituent CHS, suggesting that their effects were neither additive nor 
synergistic. However, based on the IF index, there is evidence of both additive and synergistic effects, 
which is in keeping with research on the effect of combinations of culinary and medicinal herbs on 
CRC cell growth, namely that by Yi and Wetzstein [23]. The IF data also provide evidence of 
antagonism (RTE; Table 2) despite the fact that this combination proved to be quite a potent inhibitor 
of HCA-7 cell growth as indicated by its IC50 (Table 1). It is clear that combining the CHS resulted in 
a complex set of phytochemical interactions, which regardless of their effect, be it additive, synergistic 
or antagonistic, resulted in the inhibition of HCA-7 cell growth. The overall potency of these 
combinations does indicate that they possess some chemotherapeutic potential. One limitation of this 
part of the study is that only one ratio (1:1) was used for the combinations, and from it the interaction 
factor (IF) was calculated. Although this factor is a quick method for identifying synergistic, 
antagonistic and additive effects of the combinations used, to obtain a fuller picture of the nature of 
these interactions the effect of different ratios of the same combinations needs to be investigated 
[44,45].  
Based on the SRB results, the effect of the most potent CHS on COX-2 expression was 
investigated. The present study showed that certain CHS decreased COX-2 expression at the protein 
level and also inhibited the synthesis, and consequently the release, of PGE-2. The inhibitory effect 
on PGE-2, could in part be due to a reduction in cell number caused by the treatment with CHS, 
however, a follow up experiment showed that the CHS, specifically BLE and TE, directly inhibit the 
activity of COX-2 and the synthesis of PGE-2, indicating that their effect is due to both inhibition of 
the expression and activity of COX-2 (Figures 1–3). One of the striking observations of this part of the 
present investigation was the effect of a number of the CHS (individual and in combination) on COX-
2 expression and activity (specifically PGE-2 release) in comparison to that of the COX-2 specific 
inhibitor Celecoxib, which is an established treatment for a number of conditions [46]. The effect of 
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some of the CHS was comparable to that of Celecoxib, supporting their not inconsiderable potency, 
which is likely due primarily to their polyphenol content. This is a key point to note in light of 
literature suggesting that in comparison to anti-inflammatory drugs including Celecoxib, food 
polyphenols are of limited biological relevance regarding their effect on COX-2 activity [47]. 
Although Willenberg et al. [47] investigated the effects of food polyphenols that are not major 
constituents of the CHS used in the present study, their focus on the individual constituents rather 
than their food sources may explain the lack of potency and reinforces the need to consider these 
constituents within their food matrices in which interactions likely influence the biological potency 
of the whole food.  
The individual CHS that proved to be the most potent in inhibiting COX-2 expression and 
activity (PGE-2 release and synthesis) were TE and BLE (Figures 1 and 2). Both extracts were also 
among the most potent at inhibiting HCA-7 cell growth and reducing its viability, suggesting that 
there is a link between downregulation of COX-2 expression/activity and growth inhibition. Such an 
association is supported by the work of Levi-Ari et al [47], who found that the growth inhibitory IC50 
values of curcumin were lower for a COX-2 positive cell line (HT-29; 15 μM) than SW480 (40 μM), 
which does not expresses COX-2. Studies on the anti-inflammatory properties of individual food 
polyphenols indicate that the inhibitory effect of these CHS on COX-2 is via their polyphenolic 
constituents. However, it must be borne in mind that a number of factors including the phenolic 
composition of the CHS, which varies depending on solvents used, and interactions between 
constituents likely affect their anti-inflammatory and other bioactive properties [38,48–51].  
Research has clearly established the anti-inflammatory effects of turmeric on non CRC cells are 
primarily due to the action of its major bioactive polyphenolic constituent curcumin [26]. Curcumin 
has been shown to possess a broad anti-carcinogenic activity by targeting various pro- and anti-
carcinogenic pathways [52]. Indeed, Zhang et al. [24] demonstrated that curcumin (10–20 μM) 
blocked the induction of COX-2 expression by bile and the phorbol ester (phorbol-12-myristate-13-
acetate (PMA)) in HCA-7 cells and other gastrointestinal cancer cell lines. Moreover, in the same 
study, curcumin also suppressed PGE production. Another study found that curcumin at low 
concentrations (5–75 μM) reduced COX-2 expression in HT29 cells (CRC) [26]. It is unclear how 
curcumin, and thus turmeric, act to inhibit COX-2 activity. One possible way in which this 
polyphenolic constituent affects COX-2 expression is by targeting the transcription factor NF-κB, 
which is involved in regulating COX-2 expression [53,54]. Another is via its action on activator 
protein-1 (AP-1), which is a downstream transcription factor that regulates COX-2 expression [25,55]. 
Furthermore, COX-2 is a bifunctional enzyme with cyclooxygenase and peroxidase activities. First, 
cyclooxygenase converts arachidonic acid to prostaglandin G2, which then is converted to 
prostaglandin H2 (PGH2) by the peroxidase enzyme, and then specific enzymes convert PGH2 to 
prostaglandin E2 (PGE-2) and other prostaglandins [56,57]. The bifunctional property of COX-2 may 
also be a target as curcumin inhibits both cyclooxygenase and peroxidase activities [25], which is an 
additional way through which curcumin, and thus turmeric, could reduce the level of PGE-2, and 
potentially be more advantageous in chemoprevention than non-steroidal anti-inflammatory drugs 
that only target cyclooxygenase and have no effect on the peroxidase [25]. Curcumin (~1 μM) has also 
been shown to decrease PGE-2 synthesis by inhibiting microsomal PGE-2 synthase-1 activity, which 
is functionally linked to COX-2 and is required to convert PGH2 into PGE-2 [58]. However, other 
CHS polyphenols, namely rosmarinic acid and [6]-gingerol, showed inhibitory activity against 
microsomal PGE-2 synthase-1 [58], which suggests that a very specific structure of a polyphenol is 
needed to target this enzyme.  
Curcumin may not be the only bioactive compound in turmeric that is responsible for the effects 
the authors observed in the present study as other constituents (turmerones, elemes, furanodiene, 
cyclocurcumin, bisacurone, and germacrone) of this spice have recently been identified as possessing 
anti-inflammatory activity and targeting various pro-inflammatory molecules including COX-2, 
PGE-2, and NF-κB [59]. Thus, as alluded to above, the effect of turmeric on COX-2 and PGE-2 may 
also be due to the combined effect of a number of its phytochemical constituents. 
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Regarding bay leaf and ginger, it would not be unreasonable to assume that their polyphenolic 
constituents also contributed to their COX-2/PGE-2 inhibitory action. In the present study, bay leaf, 
specifically BLE, proved to be almost as potent as that of TE. Bay leaf is a less studied herb, a small 
number of studies have reported its ability to decrease COX-2 expression (in macrophages) [60,61] 
and also to moderately inhibit COX-2 activity [42]. However, in the latter study, processed bay leaf 
(cooked and enzymatically treated) was used and the inhibition of cellular COX-2 expression and 
activity was not investigated. Willenberg et al. [46] found that naringenin and apigenin, which are 
present in this herb, reduced COX-2 expression and activity in HCA-7 cells. However, these 
polyphenols are only present in bay leaf in trace amounts [62,63] and hence are unlikely to be the 
main polyphenols responsible for the significant reduction in COX-2 expression by BLE. Other 
potential constituents (not all phenolic) that may contribute to the anti-inflammatory activity of bay 
leaf are dehydrocostus lacton, limonene, β-sitosterol, eugenol, p-coumaric acid, ferrulic acid, and 
eremanthin. However, their presence and amount can vary depending on the solvent used for the 
purposes of extraction [63,64]. Ginger (GE) also reduced COX-2 expression in the present study 
(Figures 1 and 2). However, the results suggest that its effect on activity was greater than on 
expression. Ginger extract has been shown to reduce COX-2 gene expression in another COX-2 
expressing CRC cell line—HT29 [65] and studies indicate that it is its main active phenolic 
constituents, gingerols, shogaol, and paradols that possess anti-inflammatory and anti-carcinogenic 
properties against a range of cancer, including CRC, cells [66–68]. Indeed, it has been shown that 
gingerols and shagols inhibited COX-2 activity by selectively binding to this enzyme with high 
affinity [69]. It is therefore possible that in the present study the action of the other CHS on COX-2 
activity may be due to potent polyphenolic inhibitors. 
The effect of combinations of the CHS on COX-2 expression and activity suggests that some 
additive or possibly synergistic effects came into play as some of the combinations, specifically RTE, 
BLTE, and BLSE produced slightly stronger effects than those of their constituent individual CHS 
extracts (Figures 1 and 2). Both BLTE and BLSE had synergistic effects on HCA-7 cell growth based 
on their respective Ifs, strengthening the possibility of a link between the inhibition of COX-2 and 
HCA-7 cell growth by the CHS. However, for RTE, its effect on HCA-7 cell growth was, based on its 
IF, shown to be antagonistic (Table 2). Such results highlight further the complexity of how whole 
foods in combination work as bioactive agents. Numerous factors come into play, which have already 
been touched on above and include the constituent CHS used, and the ratios of the constituents in 
the combinations. There is evidence in the literature that combining several foods can result in 
synergistic effects, suggesting that some combinations are more beneficial than the constituent single 
food [70]. However, the literature also reports that food combinations can also give rise to 
antagonistic effects [71], although this was not the case in the present study, thus highlighting the 
complexity of the “within matrix” interactions. It is clear that as with the growth inhibition results 
discussed above, the effect of such combinations require further investigation.  
The results of the present study clearly show that a selection of CHS (individually and in 
combination) inhibit the growth of the HCA-7 cell line and its COX-2 expression and activity (Figures 
1–3). It is well established that COX-2, and its product PGE-2, play an important role in carcinogenesis 
of CRC [5], including initiation of cancer cell growth, promoting proliferation, survival, angiogenesis, 
and migration, by creating a tumour-favourable microenvironment and stimulating metastasis. 
Furthermore, it has been shown that PGE-2 suppresses apoptosis and stimulates cancer cell 
proliferation [65,72]. The present study also showed, using the most potent COX-2/PGE-2 CHS 
inhibitors—BLE, BLTE, GE, TE, and SGE—that they were cytotoxic, and not cytostatic, within the 
same time frame that they were shown to inhibit COX-2 (Table 3), indicating that they acted by killing 
the cells rather than halting their proliferation. The subsequent cell cycle and apoptosis experiments, 
using BLE and TE, indicate that these extracts are capable of inducing apoptosis through the increase 
in the number of cells in the sub G1 phase, which was irreversible as confirmed by the activation of 
the apoptotic effector caspases-3 and 7 (Table 4, Figures 5 and 6). Their pro-apoptotic action (Figure 7) 
was further confirmed by the increase in cleaved caspase 3 and cleaved PARP. The effect on the 
former further indicates the growth inhibition, via apoptosis, was irreversible and was comparable 
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to that of the caspase activator Etoposide [73]. PARP protein is considered a hallmark of the apoptosis 
process and it is targeted by caspase-3 [74,75]. The results of the present study further strengthen the 
evidence that these extracts can target the pathways involving caspase-3 and cleaved PARP. Dimas 
et al. [36] reported that whole turmeric ethanol extract increased the number of CRC cells (HCT116) 
in sub G1 phase, whilst there were no changes in other cell cycle phases. In addition, studies have 
shown that curcumin is capable of activating caspase-3 [76], and increasing cleaved PARP [77]. These 
findings are very similar to those of the present study. There is relatively little known about the effect 
of bay leaf on the cell cycle and apoptosis in CRC cells with the exception of, to the authors’ 
knowledge, the work of Rodd et al. [78], who reported that unfractionated and low molecular mass 
fractions of bay leaf were pro-apoptotic (based on caspase-3/7 activity) although their impact varied. 
In addition, they halted the cell cycle via arrest in the G1/S phase. 
Regarding p53, the slight reduction in pro-apoptotic p53 caused by TE was unexpected. 
However, the HCA-7 cell line has a partially mutated/dysfunctional p53, which in fact can suppress 
apoptosis [78,79]. Thus, the most likely explanation therefore is that TE simply reduced mutated p53. 
Indeed, it has been shown that turmeric and curcumin are able to degrade mutated p53 in skin cancer 
cells [80]. Another study demonstrated that curcumin reduced levels of p53 expression in CRC cells 
(HCT15) [76]. In the present study, bay leaf (BLE) appeared to have little effect on the expression of 
p53, suggesting that its apoptotic action does not involve this protein, although further studies are 
required to confirm this observation.  
The results of the cell cycle/apoptosis analyses in the present study suggest that there is an 
association between COX-2 inhibition and apoptosis by the CHS in HCA-7 CRC cells. This suggestion 
is supported by Aggarwal et al. [81], although the focus of their study was curcumin rather than a 
selection of CHS. The same study showed that curcumin induced apoptosis in HCT116, a CRC cell 
line that does not express COX-2, although the effect was slightly lower. Therefore, the apoptotic 
action of the CHS in CRC cells may involve COX-2 dependent/independent inhibition, and the type 
of inhibition may influence their potency.  
5. Conclusions 
It is clear from the present study that the investigated CHS, both individual and in combination, 
significantly inhibited the growth, via apoptosis, of HCA-7 CRC cells within the same time frame as 
their inhibition of COX-2 expression and activity. The levels of COX-2 inhibition were similar to those 
achieved by Celecoxib, which is a strong selective COX-2 inhibitor, highlighting the possible 
therapeutic potential of these foods. Our findings also suggest that combining several CHS could 
produce beneficial growth inhibitory and anti-inflammatory effects. However, further work is 
required to ascertain whether or not the growth inhibitory effect of the CHS is influenced by COX-2 
inhibition. In addition, in light of the effect of the CHS in comparison to Celecoxib and Etoposide, 
determination of their therapeutic potential, both individually and in combination, on a larger panel 
of CRC cells is required.  
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/10/1051/s1, Figure 
S1: (a) BLE effect on HFF-2 cell growth, (b) TE effect on HFF-2 cell growth, Figure S2: (a) BLE effect on HCA-7 
cell growth, (b) TE effect on HCA-7 cell growth. 
Acknowledgments: A. Jaksevicius is the recipient of a Faculty of Science, Engineering and Computing, Kingston 
University funded Ph.D. studentship. Funding to cover the costs of open access publication will be provided by 
the Faculty of Science, Engineering and Computing, Kingston University.  
Author Contributions: A.J., M.C. and E.I.O. conceived and designed the experiments; A.J. performed the 
experiments; A.J., E.I.O. and M.C. analysed the data; H.M. contributed reagents/materials/analysis tools; and 
A.J., M.C., H.M., C.M. and E.I.O. wrote the paper  
Conflicts of Interest: The authors declare no conflict of interest. 
  
Nutrients 2017, 9, 1051 18 of 22 
 
Abbreviations 
The following abbreviations are used in this manuscript: 
A aqueous 
BLE bay leaf ethanol 
BLTE bay leaf ethanol and turmeric ethanol 
COX-2 Cyclo-ooxygenase 2 
DMEM Dulbecco’s modified Eagle’s medium 
E ethanol 
GAE gallic acid equivalent 
GE ginger ethanol 
PGE-2 prostaglandin E2 
RA rosemary aqueous 
RE rosemary ethanol 
RTE rosemary ethanol and turmeric ethanol 
SA sag aqueous 
SBLE sage ethanol and bay leaf ethanol 
SE sage ethanol 
SGE sage ethanol and ginger ethanol 
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